Found: 183
Select item for more details and to access through your institution.
Clinical outcomes and predictors of unprotected left main stem culprit lesions in patients with acute ST segment elevation myocardial infarction.
- Published in:
- Catheterization & Cardiovascular Interventions, 2014, v. 83, n. 7, p. E243, doi. 10.1002/ccd.23420
- By:
- Publication type:
- Article
Clinical outcomes of immune checkpoint inhibitors in unresectable or metastatic combined hepatocellular–cholangiocarcinoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 10, p. 7547, doi. 10.1007/s00432-023-04704-3
- By:
- Publication type:
- Article
Regorafenib versus cabozantinb as second-line treatment after sorafenib for unresectable hepatocellular carcinoma: matching-adjusted indirect comparison analysis.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 12, p. 3665, doi. 10.1007/s00432-021-03602-w
- By:
- Publication type:
- Article
Multiparametric MRI for prediction of treatment response to neoadjuvant FOLFIRINOX therapy in borderline resectable or locally advanced pancreatic cancer.
- Published in:
- European Radiology, 2021, v. 31, n. 2, p. 864, doi. 10.1007/s00330-020-07134-8
- By:
- Publication type:
- Article
Real-world data analysis of patients with cancer of unknown primary.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-02543-1
- By:
- Publication type:
- Article
Zygomycota associated with traditional meju, a fermented soybean starting material for soy sauce and soybean paste.
- Published in:
- Journal of Microbiology, 2012, v. 50, n. 3, p. 386, doi. 10.1007/s12275-012-1437-6
- By:
- Publication type:
- Article
Taxonomy of Eurotium species isolated from meju.
- Published in:
- Journal of Microbiology, 2011, v. 49, n. 4, p. 669, doi. 10.1007/s12275-011-0376-y
- By:
- Publication type:
- Article
Clinical outcomes of patients with resectable pancreatic acinar cell carcinoma.
- Published in:
- Journal of Digestive Diseases, 2017, v. 18, n. 8, p. 480, doi. 10.1111/1751-2980.12505
- By:
- Publication type:
- Article
Rivaroxaban Versus Low-molecular-weight Heparin for Venous Thromboembolism in Advanced Upper Gastrointestinal Tract and Hepatopancreatobiliary Cancer.
- Published in:
- In Vivo, 2020, v. 34, n. 2, p. 829, doi. 10.21873/invivo.11845
- By:
- Publication type:
- Article
Reduced and Normalized Carbohydrate Antigen 19-9 Concentrations after Neoadjuvant Chemotherapy Have Comparable Prognostic Performance in Patients with Borderline Resectable and Locally Advanced Pancreatic Cancer.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 5, p. 1477, doi. 10.3390/jcm9051477
- By:
- Publication type:
- Article
One Year Experience of the Hand Allotransplantation First Performed after Korea Organ Transplantation Act (KOTA) Amendment.
- Published in:
- Archives of Plastic Surgery, 2023, v. 50, n. 4, p. 415, doi. 10.1055/a-2059-5570
- By:
- Publication type:
- Article
A Retrospective Analysis of Ruptured Breast Implants.
- Published in:
- Archives of Plastic Surgery, 2014, v. 41, n. 6, p. 734, doi. 10.5999/aps.2014.41.6.734
- By:
- Publication type:
- Article
Multicenter phase II study of oral capecitabine plus irinotecan as first-line chemotherapy in advanced colorectal cancer: A Korean Cancer Study Group Trial.
- Published in:
- Acta Oncologica, 2005, v. 44, n. 3, p. 230, doi. 10.1080/02841860510029590
- By:
- Publication type:
- Article
Real-world efficacy and safety of cabozantinib in Korean patients with advanced hepatocellular carcinoma: a multicenter retrospective analysis.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221097934
- By:
- Publication type:
- Article
Real-world outcomes of adjuvant gemcitabine versus gemcitabine plus capecitabine for resected pancreatic ductal adenocarcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221097190
- By:
- Publication type:
- Article
Prognostic Relevance of p53 Overexpression in Gastrointestinal Stromal Tumors of the Small Intestine: Potential Implication for Adjuvant Treatment with Imatinib.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2015, v. 22, p. 362, doi. 10.1245/s10434-015-4506-3
- By:
- Publication type:
- Article
Intraoperatively Assessed Macroscopic Serosal Changes in Patients with Curatively Resected Advanced Gastric Cancer: Clinical Implications for Prognosis and Peritoneal Recurrence.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2015, v. 22, n. 9, p. 2940, doi. 10.1245/s10434-014-4352-8
- By:
- Publication type:
- Article
The Role of Surgical Resection Following Imatinib Treatment in Patients with Recurrent or Metastatic Gastrointestinal Stromal Tumors: Results of Propensity Score Analyses.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2014, v. 21, n. 13, p. 4211, doi. 10.1245/s10434-014-3866-4
- By:
- Publication type:
- Article
The Effects of Surgical Cytoreduction Prior to Imatinib Therapy on the Prognosis of Patients with Advanced GIST.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2013, v. 20, n. 13, p. 4212, doi. 10.1245/s10434-013-3279-9
- By:
- Publication type:
- Article
Meta-analysis examining overall survival in patients with pancreatic cancer treated with second-line 5-fluorouracil and oxaliplatin-based therapy after failing first-line gemcitabine-containing therapy: effect of performance status and comparison with other regimens.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Serum CA 19-9 as a prognostic factor in patients with metastatic gastric cancer.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2013, v. 9, n. 4, p. 324, doi. 10.1111/ajco.12019
- By:
- Publication type:
- Article
Phase II study of S-1 and irinotecan combination chemotherapy as a first-line therapy for patients with advanced gastric cancer. Korean Cancer Study Group Protocol ST05-02.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2009, v. 5, n. 1, p. 46, doi. 10.1111/j.1743-7563.2009.01191.x
- By:
- Publication type:
- Article
Synthesis of 3-phenoxy-1,3-dihydro-1-isobenzofuranones by palladium-catalyzed carbonylative cyclization of 2-bromobenzaldehyde with phenols.
- Published in:
- Journal of Heterocyclic Chemistry, 1999, v. 36, n. 4, p. 1101, doi. 10.1002/jhet.5570360446
- By:
- Publication type:
- Article
Palladium-catalyzed synthesis of 3-oxo-1,3-dihydro-1-isobenzofuranyl alkanoates from 2-bromobenzaldehyde and sodium alkanoates.
- Published in:
- Journal of Heterocyclic Chemistry, 1999, v. 36, n. 1, p. 289, doi. 10.1002/jhet.5570360145
- By:
- Publication type:
- Article
New pneumatic transfer systems for neutron activation analysis at the HANARO research reactor.
- Published in:
- Journal of Radioanalytical & Nuclear Chemistry, 2008, v. 278, n. 3, p. 707, doi. 10.1007/s10967-008-1509-6
- By:
- Publication type:
- Article
A phase 1 study of oral ASP5878, a selective small-molecule inhibitor of fibroblast growth factor receptors 1–4, as a single dose and multiple doses in patients with solid malignancies.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 2, p. 445, doi. 10.1007/s10637-019-00780-w
- By:
- Publication type:
- Article
Efficacy and safety of lanreotide in Korean patients with metastatic, well-differentiated gastroenteropancreatic-neuroendocrine tumors: a retrospective analysis.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 4, p. 763, doi. 10.1007/s10637-018-0710-x
- By:
- Publication type:
- Article
Multicenter retrospective analysis of the safety and efficacy of regorafenib after progression on sorafenib in Korean patients with hepatocellular carcinoma.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 3, p. 567, doi. 10.1007/s10637-018-0707-5
- By:
- Publication type:
- Article
Prognostic factors in patients with metastatic or recurrent pancreatic cancer treated with first-line nab-paclitaxel plus gemcitabine: implication of inflammation-based scores.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 3, p. 584, doi. 10.1007/s10637-018-0681-y
- By:
- Publication type:
- Article
Phase I/II study of first-line combination therapy with sorafenib plus resminostat, an oral HDAC inhibitor, versus sorafenib monotherapy for advanced hepatocellular carcinoma in east Asian patients.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 6, p. 1072, doi. 10.1007/s10637-018-0658-x
- By:
- Publication type:
- Article
Nab-paclitaxel plus gemcitabine versus FOLFIRINOX as the first-line chemotherapy for patients with metastatic pancreatic cancer: retrospective analysis.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 4, p. 732, doi. 10.1007/s10637-018-0598-5
- By:
- Publication type:
- Article
Germline <italic>BRCA</italic> mutations in Asian patients with pancreatic adenocarcinoma: a prospective study evaluating risk category for genetic testing.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 1, p. 163, doi. 10.1007/s10637-017-0497-1
- By:
- Publication type:
- Article
Variance of the pectoralis major in relation to the inframammary fold and the pectoralis minor and its application to breast surgery.
- Published in:
- Clinical Anatomy, 2017, v. 30, n. 3, p. 357, doi. 10.1002/ca.22834
- By:
- Publication type:
- Article
Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with regorafenib.
- Published in:
- Hepatology Research, 2021, v. 51, n. 7, p. 796, doi. 10.1111/hepr.13669
- By:
- Publication type:
- Article
How Cancer Patients Perceive Clinical Trials (CTs) in the Era of CTs: Current Perception and Its Differences Between Common and Rare Cancers.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Triclosan Resistome from Metagenome Reveals Diverse Enoyl Acyl Carrier Protein Reductases and Selective Enrichment of Triclosan Resistance Genes.
- Published in:
- Scientific Reports, 2016, p. 32322, doi. 10.1038/srep32322
- By:
- Publication type:
- Article
Phase 1/2a Study of Rivoceranib, a Selective VEGFR-2 Angiogenesis Inhibitor, in Patients with Advanced Solid Tumors.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 3, p. 743, doi. 10.4143/crt.2023.980
- By:
- Publication type:
- Article
Analysis of Plasma Circulating Tumor DNA in Borderline Resectable Pancreatic Cancer Treated with Neoadjuvant Modified FOLFIRINOX: Clinical Relevance of DNA Damage Repair Gene Alteration Detection.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 4, p. 1313, doi. 10.4143/crt.2023.452
- By:
- Publication type:
- Article
Survival Benefit of Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma Who Underwent Surgery Following Neoadjuvant FOLFIRINOX.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 3, p. 956, doi. 10.4143/crt.2022.409
- By:
- Publication type:
- Article
Adjuvant Chemotherapy for Resected Ampulla of Vater Carcinoma: Retrospective Analysis of 646 Patients.
- Published in:
- Cancer Research & Treatment, 2021, v. 53, n. 2, p. 424, doi. 10.4143/crt.2020.953
- By:
- Publication type:
- Article
Spatial Distribution and Prognostic Implications of Tumor-Infiltrating FoxPS<sup>-</sup> CD4<sup>+</sup> T Cells in Biliary Tract Cancer.
- Published in:
- Cancer Research & Treatment, 2021, v. 53, n. 1, p. 162, doi. 10.4143/crt.2020.704
- By:
- Publication type:
- Article
Systemic Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors in Korea: Literature Review and Expert Opinion.
- Published in:
- Cancer Research & Treatment, 2021, v. 53, n. 2, p. 291, doi. 10.4143/crt.2020.1233
- By:
- Publication type:
- Article
Efficacy and Safety of Pembrolizumab in Patients with Refractory Advanced Biliary Tract Cancer: Tumor Proportion Score as a Potential Biomarker for Response.
- Published in:
- Cancer Research & Treatment, 2020, v. 52, n. 2, p. 594, doi. 10.4143/crt.2019.493
- By:
- Publication type:
- Article
Clinical Outcomes of Second-Line Chemotherapy after Progression on Nab-Paclitaxel Plus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma.
- Published in:
- Cancer Research & Treatment, 2020, v. 52, n. 1, p. 254, doi. 10.4143/crt.2019.190
- By:
- Publication type:
- Article
Clinical Benefit of Maintenance Therapy for Advanced Biliary Tract Cancer Patients Showing No Progression after First-Line Gemcitabine Plus Cisplatin.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 3, p. 901, doi. 10.4143/crt.2018.326
- By:
- Publication type:
- Article
Phase I Dose-Finding Study of OPB-111077, a Novel STAT3 Inhibitor, in Patients with Advanced Hepatocellular Carcinoma.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 2, p. 510, doi. 10.4143/crt.2018.226
- By:
- Publication type:
- Article
Multicenter Phase II Study of Oxaliplatin, Irinotecan, and S-1 as First-Line Treatment for Patients with Recurrent or Metastatic Biliary Tract Cancer.
- Published in:
- Cancer Research & Treatment, 2018, v. 50, n. 4, p. 1324, doi. 10.4143/crt.2017.526
- By:
- Publication type:
- Article
Prognosis of Pancreatic Cancer Patients with Synchronous or Metachronous Malignancies from Other Organs Is Better than Those with Pancreatic Cancer Only.
- Published in:
- Cancer Research & Treatment, 2018, v. 50, n. 4, p. 1175, doi. 10.4143/crt.2017.494
- By:
- Publication type:
- Article
Efficacy and Safety of Regorafenib in Korean Patients with Advanced Gastrointestinal Stromal Tumor after Failure of Imatinib and Sunitinib: A Multicenter Study Based on the Management Access Program.
- Published in:
- Cancer Research & Treatment, 2017, v. 49, n. 2, p. 350, doi. 10.4143/crt.2016.067
- By:
- Publication type:
- Article
Real-Life Experience of Sorafenib Treatment for Hepatocellular Carcinoma in Korea: From GIDEON Data.
- Published in:
- Cancer Research & Treatment, 2016, v. 48, n. 4, p. 1243, doi. 10.4143/crt.2015.278
- By:
- Publication type:
- Article